PRO MEDICUS News & Analysis

We look at the biggest market reactions in our coverage and what our analysts think about the companies.

This week’s Investing Compass episode goes through what we can learn from top performing stocks. 

Applying lessons from a recent examination of Pro Medicus to explore the chances of another ASX share turning into the next multi-bagger.  

Market exuberance surrounds Pro Medicus with a surging share price but does the valuation match its fundamentals?

A well-known supermarket retailer and a New Zealand software giant are among Morningstar's most overvalued ASX stocks.

Materials and health stocks are among the most overvalued ASX companies under Morningstar coverage. We identify 5 to avoid at current prices.

Mid-cap stocks have been underperforming large companies on the ASX because of the greater volatility, but asset managers expect this pattern to...